Clinical Trial Update: Phase II Solar Urticaria (SU) Pilot Study [Phase 2]

View source ↗

Summary

Clinuvel's Phase II pilot study evaluating afamelanotide for solar urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solar Urticaria

Drugs mentioned

• SCENESSE (afamelanotide)

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Solar Urticaria | Phase 2 | Status: COMPLETED